Dr. Alok Kumar has finished PhD study under Prof. Tasuku Honjo (Nobel Prize, Medicine, 2018) at Kyoto University. His work on the 'Mechanism of unresponsiveness to the PD-1 blockade therapy' is internationally recognized. He obtained his master degree (M.Sc. Biotechnology) from a very reputed 'Indian Institute of Technology Roorkee, India'. During his master studies, he worked on multi-drug resistant gram negative bacteria and generated a combinatorial cocktail to inhibit their growth. His research interests includes T cell biology, immunometabolism, and cancer immunotherapy (PD-1 / CTLA-4 checkpoint blockade therapy).
Primary Affiliation: Kyoto University - Kyoto, Kyoto , Japan